mesalamine has been researched along with salicylates in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (18.92) | 18.7374 |
| 1990's | 11 (29.73) | 18.2507 |
| 2000's | 8 (21.62) | 29.6817 |
| 2010's | 10 (27.03) | 24.3611 |
| 2020's | 1 (2.70) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, RC; Hallett, MB; Laffafian, I | 1 |
| Crotty, B; Dalton, HR; Hoang, P; Jewell, DP | 1 |
| Cornett, C; Hansen, SH; Tjørnelund, J | 1 |
| Deakin, EJ; Nance, SH; Roediger, WE; Walker, G | 1 |
| Lawson, M; Nance, S; Radcliffe, B; Roediger, W; Schapel, G | 1 |
| Dull, BJ; Goldman, P; Salata, K; Van Langenhove, A | 1 |
| Fahrländer, H | 1 |
| Bramer, AM; Hughes, DE | 1 |
| Baumgarten, J; Knackmuss, HJ; Nörtemann, B; Rast, HG | 1 |
| Jewell, DP; Travis, SP | 1 |
| Almeida, LM; Dinis, TC; Maderia, VM | 1 |
| Batts, KP; Harrison, JM; Lawson, GM; Sandborn, WJ; Schroeder, KW; Steiner, BL; Tremaine, WJ; Zinsmeister, AR | 1 |
| French, DL; Mauger, JW | 1 |
| Dierickx, PJ; Janssen, L; Noble, E | 1 |
| Liu, HX; Yuan, ZB; Zhang, SS | 1 |
| Ardizzone, S; Bianchi Porro, G | 1 |
| Davaran, S; Hanaee, J; Khosravi, A | 1 |
| Cleary, CE; Malatjalian, DA; Peterson, TC; Shaw, AM; Veldhuyzen van Zanten, SJ | 1 |
| Karasyova, EI; Metelitza, DI | 1 |
| Ball, D; Day, A; Ford, J; Hearing, SD; Jobson, BA; Johnson, E; Probert, CS; Shaw, IS; Silverman, D | 1 |
| Cai, QX; Chen, D; Gao, LP; Zhu, KJ | 1 |
| ANDREWS, MM | 1 |
| Abdel-Alim, AA; Abdel-Allah, HH; Abdel-Moty, SG; El-Shorbagi, AN | 1 |
| Backhaus, B; Baenkler, HW; Buchwald, F; Hahn, EG; Kimpel, S; Koch, H; Konturek, PC; Mach, K; Naegel, A; Raithel, M; Schultis, HW | 1 |
| Chande, N; Macdonald, JK; McDonald, JW | 2 |
| Boulieu, R; Lachaux, A; Le Gall, C; Nguyen, TM | 1 |
| Blagbrough, IS; Elmasry, MS; Kheir, AA; Rogers, PJ; Rowan, MG; Saleh, HM | 1 |
| Wenzl, HH | 1 |
| Alzoubi, KH; Jilani, JA; Shomaf, M | 1 |
| Berg, AH; Cheifetz, AS; Choudhry, NK; Edwards George, JB; Horowitz, G; Leffler, DA; Lillis, Y; Moss, AC | 1 |
| Geboes, K; Jauregui-Amezaga, A; Vermeire, S | 1 |
| Ambhore, NS; Elango, K; Gupta, S; Kumar, MN; Kuppuswamy, G; Madhunapantula, SR; Mulukutla, S; Murthy, V; Raju, KR | 1 |
| Al Yatama, N; Bhanji, T; Chande, N; MacDonald, JK; McDonald, JW; Nguyen, TM | 1 |
| Chande, N; Kafil, TS; MacDonald, JK; McDonald, JW; Nguyen, TM; Patton, PH | 1 |
| Alpert, L; Colussi, D; Khalili, H; Lauwers, GY; Misdraji, J; Setia, N; Stewart, KO; van der Sloot, KW | 1 |
| Honap, S; Samaan, MA; Sharma, E | 1 |
9 review(s) available for mesalamine and salicylates
| Article | Year |
|---|---|
[Drug treatment of chronic inflammatory intestinal diseases with special reference to 5-azosalicylic acid].
Topics: Administration, Oral; Aminosalicylic Acids; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Humans; Mesalamine; Pharmaceutical Vehicles; Salicylates | 1987 |
Salicylates for inflammatory bowel disease.
Topics: Aminosalicylic Acids; Controlled Clinical Trials as Topic; Humans; Inflammatory Bowel Diseases; Mesalamine; Randomized Controlled Trials as Topic; Salicylates; Sulfasalazine | 1994 |
A practical guide to the management of distal ulcerative colitis.
Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Colitis, Ulcerative; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lipoxygenase Inhibitors; Mesalamine; Quality of Life; Salicylates; Sulfasalazine | 1998 |
Interventions for treating lymphocytic colitis.
Topics: Antidiarrheals; Bismuth; Budesonide; Cholestyramine Resin; Colitis, Lymphocytic; Humans; Mesalamine; Organometallic Compounds; Randomized Controlled Trials as Topic; Salicylates | 2008 |
Interventions for treating microscopic colitis: a Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Budesonide; Cholestyramine Resin; Colitis, Microscopic; Humans; Mesalamine; Probiotics; Randomized Controlled Trials as Topic; Salicylates | 2009 |
Diarrhea in chronic inflammatory bowel diseases.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidiarrheals; Bacterial Infections; Biopsy; Bismuth; Blood Cell Count; Blood Chemical Analysis; Body Water; Breath Tests; Budesonide; Cholestyramine Resin; Colitis, Microscopic; Diarrhea; Drug-Related Side Effects and Adverse Reactions; Endoscopy, Gastrointestinal; Feces; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Absorption; Intestinal Fistula; Intestinal Mucosa; Intestines; Ion Transport; Malabsorption Syndromes; Medical History Taking; Mesalamine; Organometallic Compounds; Physical Examination; Postoperative Complications; Prednisolone; Salicylates; Sodium; Tumor Necrosis Factor-alpha | 2012 |
Contemporary methods for the diagnosis and treatment of microscopic colitis.
Topics: Anti-Inflammatory Agents; Antidiarrheals; Bismuth; Budesonide; Colitis, Microscopic; Humans; Immunosuppressive Agents; Induction Chemotherapy; Maintenance Chemotherapy; Mesalamine; Organometallic Compounds; Probiotics; Risk Factors; Salicylates; Tumor Necrosis Factor-alpha | 2016 |
Interventions for treating lymphocytic colitis.
Topics: Anti-Inflammatory Agents; Antidiarrheals; Beclomethasone; Bismuth; Budesonide; Cholestyramine Resin; Colitis, Lymphocytic; Humans; Mesalamine; Organometallic Compounds; Randomized Controlled Trials as Topic; Salicylates | 2017 |
Interventions for treating collagenous colitis.
Topics: Bismuth; Boswellia; Budesonide; Cholestyramine Resin; Chronic Disease; Colitis, Collagenous; Diarrhea; Glucocorticoids; Humans; Mesalamine; Organometallic Compounds; Plant Extracts; Prednisolone; Probiotics; Randomized Controlled Trials as Topic; Salicylates | 2017 |
2 trial(s) available for mesalamine and salicylates
| Article | Year |
|---|---|
A placebo-controlled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis.
Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Cyclosporine; Enema; Female; Humans; Mesalamine; Middle Aged; Placebos; Salicylates | 1994 |
Significance of salicylate intolerance in diseases of the lower gastrointestinal tract.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colitis, Ulcerative; Crohn Disease; Diet; Drug Hypersensitivity; Food Hypersensitivity; Gastrointestinal Diseases; Humans; Irritable Bowel Syndrome; Lower Gastrointestinal Tract; Malabsorption Syndromes; Mesalamine; Salicylates | 2005 |
26 other study(ies) available for mesalamine and salicylates
| Article | Year |
|---|---|
The production of an amine-modified derivative of 5-aminosalicylic acid by activated neutrophils. Roles for myeloperoxidase and chloride ions.
Topics: Aminosalicylic Acids; Animals; Chlorides; Chromatography, High Pressure Liquid; Hydrogen Peroxide; Hypochlorous Acid; Mass Spectrometry; Mesalamine; Neutrophils; Peroxidase; Rats; Salicylates | 1991 |
Salicylates used in inflammatory bowel disease and colchicine impair interferon-gamma induced HLA-DR expression.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cell Line; Colchicine; Colon; Epithelium; Flow Cytometry; HLA-DR Antigens; Humans; Inflammatory Bowel Diseases; Interferon-gamma; Male; Mesalamine; Middle Aged; Salicylates | 1992 |
New metabolites of the drug 5-aminosalicylic acid. II. N-formyl-5-aminosalicylic acid.
Topics: Aminosalicylic Acids; Animals; Chromatography, High Pressure Liquid; Drug Stability; Humans; In Vitro Techniques; Liver; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mesalamine; Salicylates; Swine | 1991 |
Assessment of salicylate derivatives for potential use in ulcerative colitis: proposal for a new action of 5-aminosalicylic acid?
Topics: Aminosalicylic Acids; Animals; Carbon Dioxide; Colitis, Ulcerative; Colon; Epithelial Cells; Fatty Acids; Mesalamine; Oxidation-Reduction; Rats; Rats, Inbred Strains; Salicylates; Sodium Nitrite | 1989 |
Effect of 5-aminosalicylic acid (5-ASA) and other salicylates on short-chain fat metabolism in the colonic mucosa. Pharmacological implications for ulcerative colitis.
Topics: Aminosalicylic Acids; Animals; Cells, Cultured; Colon; Fatty Acids; Female; Humans; Intestinal Mucosa; Male; Mesalamine; Nitrites; Oxidation-Reduction; Rats; Salicylates; Structure-Activity Relationship; Sulfapyridine; Sulfasalazine | 1986 |
5-Aminosalicylate: oxidation by activated leukocytes and protection of cultured cells from oxidative damage.
Topics: Aminosalicylic Acids; Animals; Cell Line; Cell Survival; Cells, Cultured; Chromatography, High Pressure Liquid; Cricetinae; Cricetulus; Female; Free Radicals; Gentisates; Humans; Hydrogen Peroxide; Hydroxybenzoates; Leukocytes; Lymphocyte Activation; Mesalamine; Ovary; Oxidation-Reduction; Salicylates; Salicylic Acid; Superoxides | 1987 |
Anomalous liquid chromatographic results originating from the presence of soap residues and the use of nylon filters.
Topics: Aminosalicylic Acids; Chromatography, High Pressure Liquid; Filtration; Indicators and Reagents; Membranes, Artificial; Mesalamine; Nylons; Salicylates; Soaps; Surface-Active Agents | 1987 |
Bacterial communities degrading amino- and hydroxynaphthalene-2-sulfonates.
Topics: Aminosalicylic Acids; Biodegradation, Environmental; Culture Media; Fresh Water; Mesalamine; Naphthalenesulfonates; Naphthols; Pseudomonas; Salicylates; Water Microbiology | 1986 |
Action of phenolic derivatives (acetaminophen, salicylate, and 5-aminosalicylate) as inhibitors of membrane lipid peroxidation and as peroxyl radical scavengers.
Topics: Acetaminophen; Aminosalicylic Acids; Animals; Bepridil; Biphenyl Compounds; Dose-Response Relationship, Drug; Fatty Acids; Fatty Acids, Unsaturated; Ferrozine; Free Radical Scavengers; Free Radicals; Iron; Lipid Peroxidation; Mesalamine; Oxidation-Reduction; Oxygen Consumption; Peroxides; Picrates; Rabbits; Salicylates; Salicylic Acid; Sarcoplasmic Reticulum; Thiobarbituric Acid Reactive Substances | 1994 |
Evaluation of the physicochemical properties and dissolution characteristics of mesalamine: relevance to controlled intestinal drug delivery.
Topics: Acrylic Resins; Aminosalicylic Acids; Buffers; Chemical Phenomena; Chemistry, Physical; Delayed-Action Preparations; Hydrogen-Ion Concentration; Mesalamine; Polyvinyls; Salicylates; Salicylic Acid; Solubility; Spectrophotometry, Ultraviolet | 1993 |
Comparative cytotoxicity of 5-aminosalicylic acid (mesalazine) and related compounds in different cell lines.
Topics: Aminosalicylic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Line; Dogs; Glutathione; Humans; Kidney Tubules; Mesalamine; Neutral Red; Rats; Salicylates; Salicylic Acid; Structure-Activity Relationship; Swine; Tumor Cells, Cultured | 1997 |
Comparison of high-performance capillary electrophoresis and liquid chromatography on analysis of zinc 5-aminosalicylate dihydrate and related materials.
Topics: Aminophenols; Anti-Inflammatory Agents, Non-Steroidal; Buffers; Chromatography, High Pressure Liquid; Drug Stability; Electrophoresis, Capillary; Hot Temperature; Mesalamine; Reproducibility of Results; Salicylates; Salicylic Acid; Sulfuric Acids; Zinc Compounds | 1998 |
Release of 5-amino salicylic acid from acrylic type polymeric prodrugs designed for colon-specific drug delivery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Colon; Drug Delivery Systems; Hydrogen-Ion Concentration; Hydrolysis; Mesalamine; Methacrylates; Pancreatin; Polymers; Prodrugs; Salicylamides; Salicylates; Time Factors | 1999 |
Therapeutic role for bismuth compounds in TNBS-induced colitis in the rat.
Topics: Animals; Anti-Ulcer Agents; Bismuth; Colitis; Female; Mesalamine; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Salicylates; Trinitrobenzenesulfonic Acid | 2000 |
Activation of peroxidase-catalyzed oxidation of 3,3',5,5'-tetramethylbenzidine with poly(salicylic acid 5-aminodisulfide).
Topics: Antioxidants; Benzidines; Catalysis; Disulfides; Enzyme Activation; Horseradish Peroxidase; Hydrogen-Ion Concentration; Kinetics; Mesalamine; Oxidation-Reduction; Polymers; Salicylates; Structure-Activity Relationship | 2002 |
Is your patient taking the medicine? A simple assay to measure compliance with 5-aminosalicylic acid-containing compounds.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Chromatography, High Pressure Liquid; Feasibility Studies; Humans; Inflammatory Bowel Diseases; Intestines; Mesalamine; Patient Compliance; Reproducibility of Results; Salicylates; Self Administration | 2002 |
Synthesis, characterization and in vitro release of 5-aminosalicylic acid and 5-acetyl aminosalicylic acid of polyanhydride--P(CBFAS).
Topics: Aminosalicylic Acids; Animals; Anti-Inflammatory Agents; Calorimetry, Differential Scanning; Cecum; Drug Compounding; Drug Stability; Formamides; Gastrointestinal Contents; Hydrolysis; In Vitro Techniques; Magnetic Resonance Spectroscopy; Mesalamine; Molecular Weight; Prodrugs; Rats; Rats, Sprague-Dawley; Salicylates; Spectrophotometry, Infrared; Time Factors | 2003 |
The relative potencies of some substituted salicylic acids as metabolic stimulants in the intact rat.
Topics: Animals; Benzoates; Central Nervous System Agents; Central Nervous System Stimulants; Hippurates; Hydroxybenzoates; Male; Mesalamine; Metabolism; ortho-Aminobenzoates; Rats; Salicylates | 1958 |
Synthesis and anti-inflammatory testing of some new compounds incorporating 5-aminosalicylic acid (5-ASA) as potential prodrugs.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Drug Stability; Edema; Feces; Gastrointestinal Contents; Hydrogen-Ion Concentration; Lethal Dose 50; Magnetic Resonance Spectroscopy; Male; Mesalamine; Mice; Pain; Prodrugs; Rats; Salicylamides; Salicylates; Stomach Ulcer; Streptococcus pyogenes; Structure-Activity Relationship | 2005 |
High thiopurine metabolite concentrations associated with lymphopenia in inflammatory bowel disease (IBD) pediatric patients receiving aminosalicylates combined with azathioprine.
Topics: Adolescent; Aminosalicylic Acids; Azathioprine; Biotransformation; Child; Child, Preschool; Drug Therapy, Combination; Erythrocytes; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Lymphopenia; Male; Mesalamine; Purines; Salicylates; Sulfasalazine | 2010 |
Quantitative HPLC analysis of mebeverine, mesalazine, sulphasalazine and dispersible aspirin stored in a Venalink monitored dosage system with co-prescribed medicines.
Topics: Aspirin; Capsules; Chromatography, High Pressure Liquid; Drug Stability; Drug Storage; Mass Spectrometry; Medication Systems; Mesalamine; Phenethylamines; Polypharmacy; Salicylates; Sulfasalazine; Tablets; Technology, Pharmaceutical; Time Factors | 2011 |
Synthesis and evaluation of mutual azo prodrug of 5-aminosalicylic acid linked to 2-phenylbenzoxazole-2-yl-5-acetic acid in ulcerative colitis.
Topics: Acetates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzoxazoles; Colitis, Ulcerative; Disease Models, Animal; Female; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mesalamine; Prodrugs; Rats; Rats, Wistar; Salicylates; Spectrophotometry, Infrared; Trinitrobenzenesulfonic Acid | 2013 |
Attitudes to mesalamine questionnaire: a novel tool to predict mesalamine nonadherence in patients with IBD.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Attitude to Health; Cohort Studies; Colitis, Ulcerative; Female; Humans; Maintenance Chemotherapy; Male; Medication Adherence; Mesalamine; Middle Aged; Salicylates; Self Report; Surveys and Questionnaires; Young Adult | 2014 |
Salicylic acid derivatives as potential anti asthmatic agents using disease responsive drug delivery system for prophylactic therapy of allergic asthma.
Topics: Anti-Asthmatic Agents; Asthma; Drug Delivery Systems; Humans; Mesalamine; Models, Biological; NF-kappa B; Salicylates; Signal Transduction; Sodium Salicylate; Tumor Necrosis Factor-alpha | 2016 |
Lymphocytic colitis: pathologic predictors of response to therapy.
Topics: Adult; Aged; Aged, 80 and over; Antidiarrheals; Biopsy; Bismuth; Colitis, Lymphocytic; Collagen; Female; Humans; Male; Mesalamine; Middle Aged; Organometallic Compounds; Salicylates; Steroids; Treatment Outcome | 2018 |
5-ASAs in Crohn's Disease: Time to Stop the Salicylate?
Topics: Crohn Disease; Humans; Mesalamine; Salicylates | 2022 |